Teva offers to buy Mylan in $40 billion deal | The Times of Israel
Mylan (MYL) Stock Tanks After Teva Withdraws Takeover Bid - TheStreet
Teva makes $40B offer for Mylan
Big blow for Teva as FDA approves Mylan's generic Copaxone - Globes
Teva, Mylan Drop on Announcement of Epinephrine Injector Rival | Ctech
Teva shares rival Mylan's pain as both hit two-year lows | Fierce Pharma
Federal Circuit Upholds Mylan's U.S. Patents on Perforomist® Inhalation Solution; Decision Prevents Approval of Teva ANDA
Teva withdraws proposal to acquire Mylan
Drugmaker Teva makes $40B bid for rival Mylan
Teva-Makes-Hostile-Bid-Acquire
Teva, Mylan: Desperate Times Call For Desperate Measures (NYSE:TEVA) | Seeking Alpha
Mylan, Generic Copaxone Punish Teva (NYSE:TEVA) | Seeking Alpha
Teva to buy Allergan generic business for $40.5 billion, drops Mylan bid | Reuters
Teva settles litigation with Mylan over Nuvigil - Pharmaceutical Technology
Teva, Mylan to jumpstart production of old malaria drug to fight coronavirus
Teva Won't Let Regulators, Poison Pill Stop Its Quest for Mylan - TheStreet
Teva drops bid for Mylan, buys Allergan's generic drug unit - Philadelphia Business Journal
Teva Pharmaceutical Industries' quest to acquire Mylan NV could wind up in a Dutch court - Pittsburgh Business Times
Look out, Teva: Mylan's Copaxone copy has already captured serious share | Fierce Pharma
20 States Accuse Generic Drug Companies of Price Fixing - The New York Times
Teva's Generic EpiPen Will Cost As Much As Mylan's Generic | Time
Valsartan recall expands to Mylan, Teva products | Fierce Pharma
FDA swats down Teva's EpiPen copy, putting Mylan in cruise control | Fierce Pharma
Where a Teva-Mylan Deal Would Rank Among Big Pharma Companies
